Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,060 | 94,817 | 60,093 | 54,944 | 60,662 |
| Marketable Securities | 33,798 | 33,917 | 47,180 | 112,949 | 111,104 |
| Receivables | 43,606 | 53,327 | 47,487 | 54,823 | 48,199 |
| Inventories | 67,136 | 63,715 | 59,346 | 55,724 | 62,227 |
| TOTAL | $277,600 | $245,776 | $214,106 | $278,440 | $282,192 |
| Non-Current Assets | |||||
| PPE Net | 7,475 | 7,965 | 7,770 | 7,752 | 8,692 |
| Investments And Advances | 6,673 | 6,698 | 5,922 | 4,233 | 7,166 |
| Intangibles | 134,926 | 135,901 | 138,863 | 61,039 | 67,096 |
| Other Non-Current Assets | 47,112 | 49,919 | 36,520 | 48,521 | 60,368 |
| TOTAL | $196,186 | $200,483 | $189,075 | $121,545 | $143,322 |
| Total Assets | $473,785 | $446,259 | $403,181 | $399,985 | $425,514 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,210 | 5,105 | 4,555 | 4,245 | 3,319 |
| Accounts payable and accrued liabilities | 78,221 | 78,382 | 68,748 | 66,611 | 72,638 |
| TOTAL | $87,914 | $87,942 | $77,536 | $73,802 | $79,839 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 121,228 | 118,766 | 110,524 | 105,122 | 119,883 |
| TOTAL | $121,228 | $118,766 | $110,355 | $105,122 | $119,883 |
| Total Liabilities | $209,141 | $206,708 | $187,891 | $178,924 | $199,722 |
| Shareholders' Equity | |||||
| Common Shares | 7,953 | 7,821 | 7,806 | 7,769 | 7,750 |
| Retained earnings | -276,878 | -286,031 | -292,801 | -275,489 | -278,371 |
| Other shareholders' equity | 25,852 | 25,908 | 9,984 | -209 | 9,334 |
| TOTAL | $264,644 | $239,551 | $215,290 | $221,061 | $225,792 |
| Total Liabilities And Equity | $473,785 | $446,259 | $403,181 | $399,985 | $425,514 |